Media Contacts

For more information contact our media team:

Stacy Sevcik
+1 314 529 3062
Send Email >

Next Event

  • e-Health Research International Congress 2016

    Paris, France
    Oct11 – 12, 2016

    Learn More

Kantar Health thought leaders are available to comment on a variety of healthcare- and pharma-industry-related topics. In addition, our proprietary data is available for media use, including patient population sizes, treatment rates and patient-reported behaviors and attitudes.

Welcome to the Kantar Health News Room RSS Feed News

Delivering the most current and unique insights on healthcare trends and news about Kantar Health.
  • Reasons for Medication Non-Adherence Affect Patient Outcomes

    Nov 6, 2011
    Non-adherence to treatment is an important predictor of both worse clinical outcomes and higher long-term costs. However, the reasons for non-adherence are also important to consider, according to new findings from the National Health and Wellness Survey (NHWS), conducted by Kantar Health and presented today at the 14th Annual European Congress for ISPOR (International Society for Pharmacoeconomic and Outcomes Research) in Madrid, Spain.
    Continue Reading | Share
  • 40% of Patients at High Risk for Stroke Are Not Taking Anticoagulants

    Nov 6, 2011
    Nearly 40% of diagnosed “high-risk” atrial fibrillation (AF) patients in the 5EU are not taking an anticoagulant to prevent stroke, according to new findings from the National Health and Wellness Survey (NHWS), conducted by Kantar Health and presented today at the 14th ISPOR (International Society for Pharmacoeconomic and Outcomes Research) European Congress in Madrid, Spain. AF is a major independent risk factor for stroke, particularly in older patients, and patients with AF have an approximately 5% annual risk for stroke.
    Continue Reading | Share
  • Quality of Life Falls Along with Socioeconomic Status in Brazil

    Oct 26, 2011
    NEW YORK, October 26, 2011—Physical quality of life, as measured by the SF-12, is highest among the wealthiest Brazilians and falls along with one’s socioeconomic status, yet mental quality of life is the same among all Brazilians, regardless of socioeconomic profile, according to new findings from the National Health and Wellness Survey (NHWS), conducted by Kantar Health, a leading healthcare-focused global consultancy and marketing insights company.
    Continue Reading | Share
  • Annual Survey Finds That Leading Pharma Companies No Longer See Sales as the Only Measure of Success

    Oct 25, 2011
    NEW YORK, October 25, 2011—Kantar Health, a leading global, evidence-based decision support partner to the world’s leading pharmaceutical, biotech, device and diagnostic companies, recently delivered the anticipated 2011 results of its annual Stakeholder Effectiveness survey, which revealed that over two-thirds respondents from leading companies in the pharmaceutical sector think that customer retention is a key performance measure.
    Continue Reading | Share
  • PMRG Names Kantar Health’s Lynnette Cooke R.R. Fordyce award recipient

    Oct 21, 2011
    NEW YORK, October 20, 2011—Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, is pleased to announce that Global CEO Lynnette Cooke has been honored with the 2011 R.R. Fordyce Award by the Pharmaceutical Marketing Research Group (PMRG). In honor of industry leader Richard “Dick” Fordyce, this award is given each year to a recipient who exemplifies the principles of excellence, innovation and integrity in pharmaceutical market research.
    Continue Reading | Share
  • Kantar Health Adds Five New Tumor Types to CancerMPact® Treatment Architecture China

    Oct 12, 2011
    NEW YORK, October 12, 2011—Kantar Health, a leading healthcare-focused global consultancy and marketing insights company with special expertise in oncology, announces the addition of five new tumor types to CancerMPact® Treatment Architecture China. A subscription to CancerMPact® Treatment Architecture China provides in-depth analysis of the current clinical management of cancer in China by stage of disease for all treatment modalities, including chemotherapy, through multiple lines of therapy in key tumor types.
    Continue Reading | Share
  • General Practitioners: PBS Deferred Listings Will Hurt Treatment Quality

    Oct 12, 2011
    SYDNEY, September 22, 2011—Australian general practitioners (GPs) believe that the government’s deferral of listing new medicines on the Pharmaceutical Benefits Scheme (PBS) will hurt the quality of treatment that patients receive, according to research conducted by Kantar Health, a leading healthcare-focused global consultancy and marketing insights company. In addition, half of the GPs said the changes would have a negative impact on how they practice medicine.
    Continue Reading | Share
  • Kantar Health to present at EPHMRA ASIA Conference

    Oct 12, 2011
    SHANGHAI, September 21, 2011—Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, today announced that two of its thought leaders will present a training session at the EphMRA 2011 Asia Pharmaceutical Market Research Conference September 27-29 at the Kerry Hotel, Pudong, Shanghai.
    Continue Reading | Share
  • Kantar Health Launches NHWS Database in Brazil

    Oct 12, 2011
    Continue Reading | Share
  • Kantar Health Names Richard Martin CEO, Kantar Health Oncology

    Sep 9, 2011
    Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, has appointed Richard W. Martin to the position of CEO, Kantar Health Oncology. He was most recently CEO, Global Practices, at Kantar Health. In his new role, Mr. Martin will lead the continued development of Kantar Health’s global oncology business.
    Continue Reading | Share
Page